Search

Your search keyword '"Stangl, Stefan"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Stangl, Stefan" Remove constraint Author: "Stangl, Stefan" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
160 results on '"Stangl, Stefan"'

Search Results

2. Eigenspectra optoacoustic tomography achieves quantitative blood oxygenation imaging deep in tissues

7. Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC

8. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells

12. Application of High-Z Gold Nanoparticles in Targeted Cancer Radiotherapy—Pharmacokinetic Modeling, Monte Carlo Simulation and Radiobiological Effect Modeling

13. Hsp70 in Liquid Biopsies—A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer

14. Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients

15. Additional file 1 of Multi-scale Monte Carlo simulations of gold nanoparticle-induced DNA damages for kilovoltage X-ray irradiation in a xenograft mouse model using TOPAS-nBio

16. Vergleich von neun Methoden zur Berechnung von Hinterkammer-Intraokularlinsen-Stärke nach extrakapsulärer Linsenextraktion

17. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]

18. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model

19. Time- and Dose-Dependent Effects of Ionizing Irradiation on the Membrane Expression of Hsp70 on Glioma Cells

21. Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial

22. Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30)

23. Abstract 2878: Granzyme B functionalized nanocarriers targeting membrane-bound Hsp70 for multimodal cancer therapies

25. Gold Nanoparticle Mediated Multi-Modal CT Imaging of Hsp70 Membrane-Positive Tumors

29. Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer

30. Demonstrations- und Freihandexperimente zur Thermodynamik

31. Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition

32. Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG24-DFO[89Zr] for Tumor-Specific PET/CT Imaging

33. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report

34. CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma

35. Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy : a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)

36. Thermal Analysis of a Hermetic Reciprocating Compressor Using Numerical Methods

37. Experimental Study on the Thermal Behavior of a Domestic Refrigeration Compressor during Transient Operation in a Small Capacity Cooling System

38. Tumor cell-selective membrane Hsp70 targeting of malignant lesions

40. CXCR4 Labels Immune Cells in Esophageal Adenocarcinoma and Could Serve as a Pet Tracer for Diagnostics and to Monitor Therapy Response

42. Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck

44. Tumor cell-selective membrane Hsp70 targeting of malignant lesions

45. Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticles

46. Tumor cell-selective membrane Hsp70 targeting of malignant lesions

47. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer

49. Role of membrane Hsp70 in radiation sensitivity of tumor cells

Catalog

Books, media, physical & digital resources